生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Reversine, an innovative inhibitor of Aurora kinases, prevents colony formation in human acute myeloid leukemia cells. It strongly inhibits Aurora kinases A and B and moderately inhibits Aurora kinase C at a concentration of 0.5 μM. In further testing, Reversine shows an IC50 of 400 nM for Aurora kinase A, 500 nM for B, and 400 nM for C, while showing limited inhibition on other tested kinases. Additionally, the IC50 for MEK1 is >1.5 μM and for muscle myosin is 350 nM[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.54mL 0.51mL 0.25mL |
12.71mL 2.54mL 1.27mL |
25.41mL 5.08mL 2.54mL |
参考文献 |
---|